ID   RING1_HUMAN             Reviewed;         406 AA.
AC   Q06587; A8JZZ0; Q5JP96; Q5SQW2; Q86V19;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   21-MAR-2006, sequence version 2.
DT   10-MAY-2017, entry version 173.
DE   RecName: Full=E3 ubiquitin-protein ligase RING1;
DE            EC=2.3.2.27;
DE   AltName: Full=Polycomb complex protein RING1;
DE   AltName: Full=RING finger protein 1;
DE   AltName: Full=RING-type E3 ubiquitin transferase RING1 {ECO:0000305};
DE   AltName: Full=Really interesting new gene 1 protein;
GN   Name=RING1; Synonyms=RNF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=7681583; DOI=10.1073/pnas.90.6.2112;
RA   Lovering R., Hanson I.M., Borden K.L.B., Martin S., O'Reilly N.J.,
RA   Evan G.I., Rahman D., Pappin D.J.C., Trowsdale J., Freemont P.S.;
RT   "Identification and preliminary characterization of a protein motif
RT   related to the zinc finger.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:2112-2116(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   CHARACTERIZATION, AND INTERACTION WITH PHC2.
RX   PubMed=9199346; DOI=10.1128/MCB.17.7.4105;
RA   Satijn D.P.E., Gunster M.J., van der Vlag J., Hamer K.M., Schul W.,
RA   Alkema M.J., Saurin A.J., Freemont P.S., van Driel R., Otte A.P.;
RT   "RING1 is associated with the polycomb group protein complex and acts
RT   as a transcriptional repressor.";
RL   Mol. Cell. Biol. 17:4105-4113(1997).
RN   [7]
RP   CHARACTERIZATION.
RX   PubMed=9858531; DOI=10.1128/MCB.19.1.57;
RA   Satijn D.P.E., Otte A.P.;
RT   "RING1 interacts with multiple Polycomb-group proteins and displays
RT   tumorigenic activity.";
RL   Mol. Cell. Biol. 19:57-68(1999).
RN   [8]
RP   INTERACTION WITH PCGF6.
RX   PubMed=12167161; DOI=10.1046/j.1365-2443.2002.00565.x;
RA   Akasaka T., Takahashi N., Suzuki M., Koseki H., Bodmer R., Koga H.;
RT   "MBLR, a new RING finger protein resembling mammalian Polycomb gene
RT   products, is regulated by cell cycle-dependent phosphorylation.";
RL   Genes Cells 7:835-850(2002).
RN   [9]
RP   IDENTIFICATION IN A PRC1-LIKE HPRC-H COMPLEX.
RX   PubMed=12167701; DOI=10.1128/MCB.22.17.6070-6078.2002;
RA   Levine S.S., Weiss A., Erdjument-Bromage H., Shao Z., Tempst P.,
RA   Kingston R.E.;
RT   "The core of the polycomb repressive complex is compositionally and
RT   functionally conserved in flies and humans.";
RL   Mol. Cell. Biol. 22:6070-6078(2002).
RN   [10]
RP   IDENTIFICATION IN COMPLEX WITH E2F6; TFDP1; MAX; MGA; EUHMTASE1; BAT8;
RP   CBX3; RNF2; MBLR; L3MBTL2 AND YAF2.
RX   PubMed=12004135; DOI=10.1126/science.1069861;
RA   Ogawa H., Ishiguro K., Gaubatz S., Livingston D.M., Nakatani Y.;
RT   "A complex with chromatin modifiers that occupies E2F- and Myc-
RT   responsive genes in G0 cells.";
RL   Science 296:1132-1136(2002).
RN   [11]
RP   IDENTIFICATION IN A PRC1-LIKE COMPLEX WITH RNF2; BMI1 AND PHC2.
RX   PubMed=15386022; DOI=10.1038/nature02985;
RA   Wang H., Wang L., Erdjument-Bromage H., Vidal M., Tempst P.,
RA   Jones R.S., Zhang Y.;
RT   "Role of histone H2A ubiquitination in Polycomb silencing.";
RL   Nature 431:873-878(2004).
RN   [12]
RP   FUNCTION.
RX   PubMed=16359901; DOI=10.1016/j.molcel.2005.12.002;
RA   Cao R., Tsukada Y., Zhang Y.;
RT   "Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene
RT   silencing.";
RL   Mol. Cell 20:845-854(2005).
RN   [13]
RP   INTERACTION WITH RYBP; PCGF1; BCOR AND RNF2.
RX   PubMed=16943429; DOI=10.1128/MCB.00630-06;
RA   Gearhart M.D., Corcoran C.M., Wamstad J.A., Bardwell V.J.;
RT   "Polycomb group and SCF ubiquitin ligases are found in a novel BCOR
RT   complex that is recruited to BCL6 targets.";
RL   Mol. Cell. Biol. 26:6880-6889(2006).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-38, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-38; SER-187 AND SER-190,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   IDENTIFICATION IN A PRC1-LIKE COMPLEX, AND INTERACTION WITH PCGF2.
RX   PubMed=19636380; DOI=10.1371/journal.pone.0006380;
RA   Maertens G.N., El Messaoudi-Aubert S., Racek T., Stock J.K.,
RA   Nicholls J., Rodriguez-Niedenfuhr M., Gil J., Peters G.;
RT   "Several distinct polycomb complexes regulate and co-localize on the
RT   INK4a tumor suppressor locus.";
RL   PLoS ONE 4:E6380-E6380(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-220, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140; SER-248 AND
RP   SER-254, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   IDENTIFICATION IN A PRC1-LIKE COMPLEX, INTERACTION WITH CBX6; CBX7 AND
RP   CBX8, AND SUBCELLULAR LOCATION.
RX   PubMed=21282530; DOI=10.1074/mcp.M110.002642;
RA   Vandamme J., Volkel P., Rosnoblet C., Le Faou P., Angrand P.O.;
RT   "Interaction proteomics analysis of polycomb proteins defines distinct
RT   PRC1 Complexes in mammalian cells.";
RL   Mol. Cell. Proteomics 0:0-0(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-38; SER-140 AND SER-229,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-24; SER-38; SER-187;
RP   THR-215; THR-220; SER-229 AND SER-232, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   VARIANT GLN-95.
RX   PubMed=25725044; DOI=10.1136/jmedgenet-2014-102813;
RA   Blanchard M.G., Willemsen M.H., Walker J.B., Dib-Hajj S.D.,
RA   Waxman S.G., Jongmans M.C., Kleefstra T., van de Warrenburg B.P.,
RA   Praamstra P., Nicolai J., Yntema H.G., Bindels R.J., Meisler M.H.,
RA   Kamsteeg E.J.;
RT   "De novo gain-of-function and loss-of-function mutations of SCN8A in
RT   patients with intellectual disabilities and epilepsy.";
RL   J. Med. Genet. 52:330-337(2015).
CC   -!- FUNCTION: Constitutes one of the E3 ubiquitin-protein ligases that
CC       mediate monoubiquitination of 'Lys-119' of histone H2A, thereby
CC       playing a central role in histone code and gene regulation. H2A
CC       'Lys-119' ubiquitination gives a specific tag for epigenetic
CC       transcriptional repression and participates in X chromosome
CC       inactivation of female mammals. Essential component of a Polycomb
CC       group (PcG) multiprotein PRC1-like complex, a complex class
CC       required to maintain the transcriptionally repressive state of
CC       many genes, including Hox genes, throughout development. PcG PRC1
CC       complex acts via chromatin remodeling and modification of
CC       histones, rendering chromatin heritably changed in its
CC       expressibility. Compared to RNF2/RING2, it does not have the main
CC       E3 ubiquitin ligase activity on histone H2A, and it may rather act
CC       as a modulator of RNF2/RING2 activity.
CC       {ECO:0000269|PubMed:16359901}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Component of chromatin-associated Polycomb (PcG)
CC       complexes. Interacts with BMI1 (By similarity). Part of the
CC       E2F6.com-1 complex in G0 phase composed of E2F6, MGA, MAX, TFDP1,
CC       CBX3, BAT8, EUHMTASE1, RING1, RNF2/RING2 MBLR, L3MBTL2 and YAF2.
CC       Interacts with CBX2 and PCGF6. Component of a PRC1-like complex.
CC       Component of repressive BCOR complex containing Polycomb group
CC       subcomplex at least composed of RYBP, PCGF1, BCOR and RNF2/RING2.
CC       Interacts with PCGF2, RNF2; CBX6, CBX7 and CBX8. Interacts with
CC       PHC2 (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P35226:BMI1; NbExp=16; IntAct=EBI-752313, EBI-2341576;
CC       O95503:CBX6; NbExp=5; IntAct=EBI-752313, EBI-3951758;
CC       O95931:CBX7; NbExp=5; IntAct=EBI-752313, EBI-3923843;
CC       Q9HC52:CBX8; NbExp=13; IntAct=EBI-752313, EBI-712912;
CC       Q9BSM1:PCGF1; NbExp=8; IntAct=EBI-752313, EBI-749901;
CC       P35227:PCGF2; NbExp=11; IntAct=EBI-752313, EBI-2129767;
CC       Q3KNV8:PCGF3; NbExp=4; IntAct=EBI-752313, EBI-2339807;
CC       Q86SE9:PCGF5; NbExp=6; IntAct=EBI-752313, EBI-2827999;
CC       Q9BYE7:PCGF6; NbExp=3; IntAct=EBI-752313, EBI-1048026;
CC       Q99496:RNF2; NbExp=5; IntAct=EBI-752313, EBI-722416;
CC       Q8N488:RYBP; NbExp=14; IntAct=EBI-752313, EBI-752324;
CC       P51668:UBE2D1; NbExp=3; IntAct=EBI-752313, EBI-743540;
CC       Q9Y2X8:UBE2D4; NbExp=3; IntAct=EBI-752313, EBI-745527;
CC       P51784:USP11; NbExp=4; IntAct=EBI-752313, EBI-306876;
CC       Q93009:USP7; NbExp=5; IntAct=EBI-752313, EBI-302474;
CC       Q8IY57:YAF2; NbExp=6; IntAct=EBI-752313, EBI-2842031;
CC       Q8IY57-5:YAF2; NbExp=4; IntAct=EBI-752313, EBI-12111538;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21282530}.
CC       Nucleus speckle {ECO:0000269|PubMed:21282530}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q06587-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q06587-2; Sequence=VSP_017694;
CC   -!- MISCELLANEOUS: The hPRC-H complex purification reported by
CC       PubMed:12167701 probably presents a mixture of different PRC1-like
CC       complexes.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z14000; CAA78389.1; -; mRNA.
DR   EMBL; BT007352; AAP36016.1; -; mRNA.
DR   EMBL; AK289355; BAF82044.1; -; mRNA.
DR   EMBL; AL031228; CAA20235.1; -; Genomic_DNA.
DR   EMBL; AL031228; CAI95620.1; -; Genomic_DNA.
DR   EMBL; AL713971; CAI17650.1; -; Genomic_DNA.
DR   EMBL; AL645940; CAI18069.1; -; Genomic_DNA.
DR   EMBL; AL844527; CAI41841.1; -; Genomic_DNA.
DR   EMBL; CR759786; CAQ08246.1; -; Genomic_DNA.
DR   EMBL; CR759733; CAQ10303.1; -; Genomic_DNA.
DR   EMBL; CR847841; CAQ10314.1; -; Genomic_DNA.
DR   EMBL; CR547129; CAQ10314.1; JOINED; Genomic_DNA.
DR   EMBL; CR547129; CAQ10355.1; -; Genomic_DNA.
DR   EMBL; CR847841; CAQ10355.1; JOINED; Genomic_DNA.
DR   EMBL; BC002922; AAH02922.2; -; mRNA.
DR   EMBL; BC051866; AAH51866.1; -; mRNA.
DR   CCDS; CCDS34424.1; -. [Q06587-1]
DR   PIR; A47380; A47380.
DR   RefSeq; NP_002922.2; NM_002931.3. [Q06587-1]
DR   UniGene; Hs.631989; -.
DR   ProteinModelPortal; Q06587; -.
DR   SMR; Q06587; -.
DR   BioGrid; 111947; 72.
DR   DIP; DIP-42043N; -.
DR   IntAct; Q06587; 68.
DR   MINT; MINT-1327105; -.
DR   STRING; 9606.ENSP00000363787; -.
DR   iPTMnet; Q06587; -.
DR   PhosphoSitePlus; Q06587; -.
DR   BioMuta; RING1; -.
DR   DMDM; 90110053; -.
DR   EPD; Q06587; -.
DR   MaxQB; Q06587; -.
DR   PaxDb; Q06587; -.
DR   PeptideAtlas; Q06587; -.
DR   PRIDE; Q06587; -.
DR   TopDownProteomics; Q06587-1; -. [Q06587-1]
DR   TopDownProteomics; Q06587-2; -. [Q06587-2]
DR   DNASU; 6015; -.
DR   Ensembl; ENST00000374656; ENSP00000363787; ENSG00000204227. [Q06587-1]
DR   Ensembl; ENST00000383212; ENSP00000372699; ENSG00000206287. [Q06587-1]
DR   Ensembl; ENST00000415941; ENSP00000412190; ENSG00000226788. [Q06587-1]
DR   Ensembl; ENST00000427374; ENSP00000400572; ENSG00000231115. [Q06587-1]
DR   Ensembl; ENST00000430233; ENSP00000396271; ENSG00000228520. [Q06587-1]
DR   Ensembl; ENST00000436128; ENSP00000396439; ENSG00000235107. [Q06587-1]
DR   GeneID; 6015; -.
DR   KEGG; hsa:6015; -.
DR   UCSC; uc003odk.4; human. [Q06587-1]
DR   CTD; 6015; -.
DR   DisGeNET; 6015; -.
DR   GeneCards; RING1; -.
DR   HGNC; HGNC:10018; RING1.
DR   HPA; HPA008701; -.
DR   MIM; 602045; gene.
DR   neXtProt; NX_Q06587; -.
DR   OpenTargets; ENSG00000204227; -.
DR   PharmGKB; PA34393; -.
DR   eggNOG; KOG0311; Eukaryota.
DR   eggNOG; ENOG410XQ5G; LUCA.
DR   GeneTree; ENSGT00390000016977; -.
DR   HOGENOM; HOG000273917; -.
DR   HOVERGEN; HBG079942; -.
DR   InParanoid; Q06587; -.
DR   KO; K10695; -.
DR   OMA; QSASKTW; -.
DR   OrthoDB; EOG091G06VO; -.
DR   PhylomeDB; Q06587; -.
DR   TreeFam; TF105501; -.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-3108214; SUMOylation of DNA damage response and repair proteins.
DR   Reactome; R-HSA-4570464; SUMOylation of RNA binding proteins.
DR   SIGNOR; Q06587; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; RING1; human.
DR   GeneWiki; RING1; -.
DR   GenomeRNAi; 6015; -.
DR   PRO; PR:Q06587; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000204227; -.
DR   CleanEx; HS_RING1; -.
DR   Genevisible; Q06587; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0031519; C:PcG protein complex; IDA:UniProtKB.
DR   GO; GO:0035102; C:PRC1 complex; IDA:UniProtKB.
DR   GO; GO:0001739; C:sex chromatin; IEA:Ensembl.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0016740; F:transferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0097027; F:ubiquitin-protein transferase activator activity; IEA:Ensembl.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0048593; P:camera-type eye morphogenesis; IEA:Ensembl.
DR   GO; GO:0035518; P:histone H2A monoubiquitination; IDA:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR032443; RAWUL.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   Pfam; PF16207; RAWUL; 1.
DR   SMART; SM00184; RING; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromatin regulator; Complete proteome;
KW   Metal-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Transferase; Ubl conjugation pathway; Zinc;
KW   Zinc-finger.
FT   CHAIN         1    406       E3 ubiquitin-protein ligase RING1.
FT                                /FTId=PRO_0000056384.
FT   ZN_FING      48     88       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   REGION       30    234       Necessary for transcriptional repression.
FT                                {ECO:0000250}.
FT   REGION      230    406       Necessary for interaction with CBX2.
FT                                {ECO:0000250}.
FT   MOTIF       201    204       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   COMPBIAS    205    260       Gly-rich.
FT   COMPBIAS    314    377       Gly-rich.
FT   MOD_RES      24     24       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      38     38       Phosphoserine.
FT                                {ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     140    140       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     187    187       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     190    190       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     215    215       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     220    220       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     229    229       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     232    232       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     248    248       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     254    254       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   VAR_SEQ       1     29       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:7681583,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_017694.
FT   VARIANT      95     95       R -> Q. {ECO:0000269|PubMed:25725044}.
FT                                /FTId=VAR_076618.
SQ   SEQUENCE   406 AA;  42429 MW;  6959787479DE9DAB CRC64;
     MTTPANAQNA SKTWELSLYE LHRTPQEAIM DGTEIAVSPR SLHSELMCPI CLDMLKNTMT
     TKECLHRFCS DCIVTALRSG NKECPTCRKK LVSKRSLRPD PNFDALISKI YPSREEYEAH
     QDRVLIRLSR LHNQQALSSS IEEGLRMQAM HRAQRVRRPI PGSDQTTTMS GGEGEPGEGE
     GDGEDVSSDS APDSAPGPAP KRPRGGGAGG SSVGTGGGGT GGVGGGAGSE DSGDRGGTLG
     GGTLGPPSPP GAPSPPEPGG EIELVFRPHP LLVEKGEYCQ TRYVKTTGNA TVDHLSKYLA
     LRIALERRQQ QEAGEPGGPG GGASDTGGPD GCGGEGGGAG GGDGPEEPAL PSLEGVSEKQ
     YTIYIAPGGG AFTTLNGSLT LELVNEKFWK VSRPLELCYA PTKDPK
//
